MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) IS ASSOCIATED WITH THE PROGRESSION OF STRUCTURAL BONE DAMAGE IN RHEUMATOID ARTHRITIS PATIENTS IN REMISSION

Schett G, Finzel S, Hagen M, Englbrecht M, Haschka J, Figuereido C, Cobra JF, Rech J (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Book Volume: 76

Pages Range: 236-236

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III Melanie Hagen Department of Medicine 3 – Rheumatology and Immunology Matthias Englbrecht Lehrstuhl für Innere Medizin III Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Medizinische Universität Wien AT Austria (AT) Universitätsklinikum Freiburg DE Germany (DE)

How to cite

APA:

Schett, G., Finzel, S., Hagen, M., Englbrecht, M., Haschka, J., Figuereido, C.,... Rech, J. (2017). MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) IS ASSOCIATED WITH THE PROGRESSION OF STRUCTURAL BONE DAMAGE IN RHEUMATOID ARTHRITIS PATIENTS IN REMISSION. (pp. 236-236).

MLA:

Schett, Georg, et al. "MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) IS ASSOCIATED WITH THE PROGRESSION OF STRUCTURAL BONE DAMAGE IN RHEUMATOID ARTHRITIS PATIENTS IN REMISSION." 2017. 236-236.

BibTeX: Download